Your browser doesn't support javascript.
loading
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.
Cardone, Claudia; Martinelli, Erika; Troiani, Teresa; Sforza, Vincenzo; Avallone, Antonio; Nappi, Anna; Montesarchio, Vincenzo; Andreozzi, Francesca; Biglietto, Maria; Calabrese, Filomena; Bordonaro, Roberto; Cordio, Stefano; Bregni, Giacomo; Febbraro, Antonio; Garcia-Carbonero, Rocio; Feliu, Jaime; Cervantes, Andrés; Ciardiello, Fortunato.
Afiliación
  • Cardone C; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
  • Martinelli E; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
  • Troiani T; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
  • Sforza V; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
  • Avallone A; Department of Experimental Medicine, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Nappi A; Department of Experimental Medicine, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
  • Montesarchio V; Azienda Ospedaliera dei Colli, Medical Oncology, Monaldi Hospital, Napoli, Italy.
  • Andreozzi F; Azienda Ospedaliera dei Colli, Medical Oncology, Monaldi Hospital, Napoli, Italy.
  • Biglietto M; Medical Oncology, Antonio Cardarelli Hospital, Napoli, Italy.
  • Calabrese F; Medical Oncology, Antonio Cardarelli Hospital, Napoli, Italy.
  • Bordonaro R; Medical Oncology, National Specialist Hospital Garibaldi, Catania, Italy.
  • Cordio S; Medical Oncology, National Specialist Hospital Garibaldi, Catania, Italy.
  • Bregni G; Medical Oncology, Hospital San Martino, Genova, Italy.
  • Febbraro A; Medical Oncology, Hospital Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy.
  • Garcia-Carbonero R; Medical Oncology, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Feliu J; CIBERONC, Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
  • Cervantes A; CIBERONC, Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Ciardiello F; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
ESMO Open ; 4(4): e000519, 2019.
Article en En | MEDLINE | ID: mdl-31555481
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: ESMO Open Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: ESMO Open Año: 2019 Tipo del documento: Article País de afiliación: Italia